Is UnitedHealth Group Stock a Buy After Another Solid Quarter?
The healthcare giant recently posted its third-quarter earnings, which came in better than expected.
UnitedHealth Group (UNH) has recently posted a robust quarter, with revenue reaching $112.7 billion, surpassing analysts' expectations of $111.4 billion for the period ending September 30th. Adjusted earnings per share (EPS) stood at $4.69, outperforming the forecasted $4.14. Consequently, the healthcare provider increased its guidance, anticipating adjusted EPS to be at least $20.50 for the year, an improvement from the previous range of $19.50 to $20.
The company's strategic moves, including exiting unprofitable markets and investing in artificial intelligence (AI), have contributed to its improved financial performance. UnitedHealth's stock, trading at around $401, is currently relatively affordable, boasting a forward price-to-earnings multiple of approximately 16, which is lower than the S&P 500's average of over 19.
With a dividend yielding 2.3%, UnitedHealth Group presents itself as a compelling long-term investment, offering both value and stability while providing attractive income for investors.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
